Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Alimentary Pharmacology & Therapeutics|September 27, 2016
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's diseaseJ Cosnes, H Sokol, A Bourrier, et al.
Inflammatory Bowel Diseases|August 20, 2010
Highlighting new phylogenetic specificities of Crohn's disease microbiotaS Mondot, S Kang, J P Furet, et al.
The Journal of Nutrition|January 23, 1999
Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humansY Bouhnik, K Vahedi, L Achour, et al.
Biochimie|May 20, 1998
Casein peptide release and passage to the blood in humans during digestion of milk or yogurtB Chabance, P Marteau, J C Rambaud, et al.
Inflammatory Bowel Diseases|February 25, 2009
Low counts of Faecalibacterium prausnitzii in colitis microbiotaH Sokol, P Seksik, J P Furet, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled studyP Marteau, E Cuillerier, S Meance, et al.
Gastroenterology|January 1, 1993
Alpha-chain disease: analysis of alpha-chain protein and secretory component in jejunal fluidD Lucidarme, J F Colombel, P Brandtzaeg, et al.
Alimentary Pharmacology & Therapeutics|November 10, 2015
Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort studyA Bourrier, F Carrat, J-F Colombel, et al.
Pageof 13